CAS 140932-79-2 Balhimycin CAS Nr

Xa kev nug
CAS 140932-79-2 Balhimycin CAS Nr
Paub meej
CAS: 140932-79-2 Nr
Cov qauv tseem ceeb: Heptapeptide glycopeptide tshuaj tua kab mob nrog kev hloov kho chloro thiab glucosyl
Kev hloov pauv, triphenyl ether caj qaum cyclization
Peb kuj muab cov lus qhia tshwj xeeb los ntawm crude mus rau 99% purity, thov hu rau peb kom paub meej!

Cov ntaub ntawv ntsig txog
COA/MS/HPLC Report
Peptide Dissolution thiab Cia Phau Ntawv Qhia
Qeb
Glycopeptide Tshuaj tua kab mob / Cell Phab ntsa Synthesis Inhibitor
Kev faib tawm yam khoom
Pharmaceutical Peptides
Share to
Hauj lwm lawm

Shanghai Sonyt Biotechnology Co., Ltd. yog ib qho ntawm cov ua lag luam thiab cov neeg muag khoom ntawm cas 140932-79-2 balhimycin hauv Suav teb, kuj txhawb kev pabcuam kev cai. Txais tos rau cov lag luam wholesale bulk zoo cas 140932-79-2 balhimycin los ntawm peb lub hoobkas. Tiv tauj peb kom paub meej ntxiv.

 

CAS Nr .: 140932-79-2 Balhimycin
Kev piav qhia Balhimycin yog vancomycin-class glycopeptide tshuaj tua kab mob. Nws khi rau D-Ala-D-Ala terminus ntawm cov kab mob cell phab ntsa peptidoglycan precursors, inhibits peptidoglycan cross-linking synthesis, thiab nthuav tawm cov kab mob muaj zog tiv thaiv kab mob Gram-positive nrog rau MRSA. Siv rau hauv kev tshawb fawb cov kab mob-resistant tshuaj, glycopeptide SAR tsom xam thiab kev txhim kho tshuaj tua kab mob.
Purity (HPLC, %) 90%/95%/98%
Cov mis mos molecular C₆₆H₇₃Cl₂N₉O₂₄
Molecular Luj (Da) 1447.25
Hom qauv Tricyclic glycopeptide nrog kev hloov kho monoglucosyl

 

Khoom Description

 

Khoom Lub Npe Lus Askiv Product Abbreviation / Alias Function Tags (comma-sib cais) Core Structure Molecular Formula Exact Mass (Da) Nruab nrab MW (Da) Hom qauv Antimicrobial Spectrum
Balhimycin; Vancomycin analogue; CAS Nr .: 140932-79-2 Glycopeptide tshuaj tua kab mob, Cell phab ntsa synthesis inhibition, Anti-MRSA, Peptidoglycan binding, Tshuaj- tiv thaiv kab mob tshawb fawb, SAR tsom xam Heptapeptide tricyclic qaum nrog ob qho tshuaj chlorine hloov, hloov kho glucosyl, tsis muaj oxygen -muaj suab thaj moiety C₆₆H₇₃Cl₂N₉O₂₄ 1445.41 1447.25 Tsis yog -ribosomal glycopeptide tshuaj tua kab mob Gram{0}}cov kab mob zoo xws li MRSA

 

Physicochemical Solubility & Cia Parameters

 

Khoom Code Qhov tshwm sim Ntev - Lub Sij Hawm Cia Cov Cai Luv -Lub Sijhawm Cia Cov Cai Kua Stability Khoom hmoov ruaj khov
PEB-BAL001 hmoov dawb Khaws ntawm -20 degree, kaw, qhuav & tiv thaiv los ntawm lub teeb, aliquoted; tsis txhob kub siab thiab muaj zog acid / puag Khoom hmoov ruaj khov rau 3 xyoos ntawm 2-8℃kaw thiab qhuav; npaj cov kev daws teeb meem npaj nyob rau hauv dilute acid buffer ruaj khov rau 1 lub hlis ntawm 4℃nyob rau hauv nruab nrab tej yam kev mob; ruaj khov rau 6 lub hlis ntawm -20℃hauv aliquots. ** Dej solubility nruab nrab, dawb soluble nyob rau hauv dilute acetic acid thiab aqueous organic solvents **. Sai sai degraded nyob rau hauv alkaline tej yam kev mob. Phenolic hydroxyl pawg nquag oxidation, yuav tsum muaj kev tiv thaiv lub teeb ruaj khov rau ntau tshaj 3 xyoos ntawm -20℃nyob rau hauv qhuav & tsaus ntuj

 

Functional Description

 

Khoom Code Frontend Short Summary (rau cov npe tshawb nrhiav) Cov lus piav qhia txog kev ua haujlwm lom neeg lom neeg Cov cheeb tsam tshawb fawb (comma- cais) Lub Hom Phiaj / Txoj Kev
PEB-BAL001 Vancomycin-chav kawm tricyclic glycopeptide tshuaj tua kab mob uas khi peptidoglycan D-Ala-D-Ala terminus los inhibit cell phab ntsa synthesis, anti-MRSA Balhimycin yog ib hom tshuaj tua kab mob glycopeptide uas tsim los ntawm Actinomycetes fermentation, heev homologous rau vancomycin hauv cov qauv, nrog cov yam ntxwv heptapeptide tricyclic qaum thiab chlorinated benzene nplhaib hloov. Nws cov txheej txheem ntawm kev ua yog zoo ib yam nrog vancomycin: nws khi nrog siab affinity ntawm hydrogen daim ntawv cog lus rau D-Ala-D-Ala dipeptide terminus ntawm cov kab mob cell phab ntsa peptidoglycan precursors, sterically blocks transglycosylase thiab transpeptidase chain binding, cross-txuas txuas, cuam tshuam cov phab ntsa ntawm tes, thiab thaum kawg ua rau cov kab mob osmotic lysis. Cov molecule no nthuav tawm cov kab mob muaj zog tiv thaiv kab mob Gram- cov kab mob zoo xws li Staphylococcus aureus, Streptococcus thiab Enterococcus, thiab tseem muaj txiaj ntsig tiv thaiv cov tshuaj tiv thaiv kab mob xws li MRSA. Nws ua haujlwm raws li cov cuab yeej tseem ceeb hauv kev tshawb fawb glycopeptide tshuaj tua kab mob SAR, kev tshuaj xyuas cov txheej txheem tiv thaiv, thiab kev txhim kho tshuaj tshiab glycopeptide. Tshuaj-kev tshawb fawb tiv thaiv kab mob, kev tshawb fawb tshuaj tua kab mob Glycopeptide, Kev tshawb fawb kab mob ntawm cov phab ntsa ntawm tes, kev tshawb fawb MRSA, Tshuaj tua kab mob SAR, kev tshawb fawb tshuaj microbial Bacterial peptidoglycan precursor D-Ala-D-Ala terminus; Peptidoglycan transglycosylase / transpeptidase inhibition; Cell phab ntsa biosynthesis blockade txoj kev

Cim npe nrov: CAS 140932-79-2 balhimycin, Tuam Tshoj cas 140932-79-2 balhimycin manufacturers, lwm tus, Hoobkas

Xa kev nug